FindOwnerSearch
Brands and Their Owners
Welcome to the Brand page for “HYFC”, which is offered here for Pharmaceuticals; vaccines; anti-cancer preparations; antibiotics; antibiotic preparations; pills for inflammation treatment; cardiovascular pharmaceutical preparations; medicines for sensory organs; pharmaceutical preparations for digestive organs; dermatological pharmaceutical products; blood solvent; agents affecting metabolism; anti-inflammatory preparations; disinfectants for hygiene purposes; fungicides; medicated candy; agents for treatment of diabetes; asthmatic agents; immunoglobulin fusion protein agents; medicines for the treatment of neutropenia; medicines for the treatment of anemia; medicines for the treatment of dwarfism; medicines for the treatment of inflammatory bowel disease; medicines for the treatment of short-bowel syndrome; medicines for the treatment of psoriasis; medicines for the treatment of proliferative arthritis; medicines for the treatment of systemic lupus erythematosus; medicines for the treatment of cervical tumor;.
Its status is currently believed to be active. Its class is unavailable. “HYFC” is believed to be currently owned by “Genexine, Inc.”
| Owner: |
GENEXINE, INC.
Owner Details |
|---|---|
| Description: |
Pharmaceuticals; vaccines; anti-cancer preparations; antibiotics; antibiotic preparations; pills for inflammation treatment; cardiovascular pharmaceutical preparations; medicines for sensory organs; pharmaceutical preparations for digestive organs; dermatological pharmaceutical products; blood solvent; agents affecting metabolism; anti-inflammatory preparations; disinfectants for hygiene purposes; fungicides; medicated candy; agents for treatment of diabetes; asthmatic agents; immunoglobulin fusion protein agents; medicines for the treatment of neutropenia; medicines for the treatment of anemia; medicines for the treatment of dwarfism; medicines for the treatment of inflammatory bowel disease; medicines for the treatment of short-bowel syndrome; medicines for the treatment of psoriasis; medicines for the treatment of proliferative arthritis; medicines for the treatment of systemic lupus erythematosus; medicines for the treatment of cervical tumor;
|
| Categories: | PHARMACEUTICALS |